April 30, 2019
Allegro Ophthalmics to Present the Results of Its ALG-1007 Ex-U.S. Trial for Dry Eye Disease at the 2019 ASCRS•ASOA Annual Meeting
ALG-1007 Marks Allegro’s Second Exploratory Anti-Integrin Drug Candidate—Now, for the Potential Treatment of Dry Eye Disease SAN JUAN CAPISTRANO, Calif.–(BUSINESS…